Agammaglobulinemia type 2, caused by mutations in the IGLL1 gene, is a rare genetic disorder that affects the immune system. This condition is characterized by an almost complete absence of immunoglobulins or antibodies, which are crucial for fighting infections. As a result, individuals with this condition are more susceptible to infections from an early age. Understanding the symptoms and the availability of genetic testing for this condition is vital for early diagnosis and management. DNA Labs UAE offers a comprehensive genetic test for IGLL1 Gene Agammaglobulinemia type 2 autosomal recessive condition, priced at 4400 AED. More information about this test can be found at [DNA Labs UAE](https://dnalabsuae.com/tests/igll1-gene-agammaglobulinemia-type-2-autosomal-recessive-genetic-test/).
Symptoms of IGLL1 Gene Agammaglobulinemia Type 2
Individuals with IGLL1 Gene Agammaglobulinemia type 2 typically present a range of symptoms from early childhood, although the onset and severity can vary. Recognizing these symptoms early can be crucial for timely intervention and management of the condition.
-
Recurrent Infections: Due to the lack of antibodies, affected individuals are prone to recurrent bacterial infections. These infections often involve the ears, sinuses, lungs, and gastrointestinal tract.
-
Poor Growth: Chronic infections can lead to poor growth and development in children.
-
Autoimmune Disorders: Some individuals may develop autoimmune disorders, where the immune system mistakenly attacks the body’s own cells.
-
Delayed or Absent Secondary Sexual Characteristics: In some cases, puberty may be delayed or secondary sexual characteristics may be absent due to the impact of chronic illness on development.
It is important to note that the severity and specific symptoms can vary widely among individuals. Early diagnosis and treatment are crucial for improving the quality of life for those affected by this condition.
Genetic Testing for IGLL1 Gene Agammaglobulinemia Type 2
Genetic testing plays a pivotal role in the diagnosis of IGLL1 Gene Agammaglobulinemia type 2. DNA Labs UAE offers a specific genetic test for this condition, which can confirm the diagnosis and help in planning the appropriate management and treatment strategies. The test is priced at 4400 AED.
The genetic test involves analyzing the DNA to look for mutations in the IGLL1 gene that are known to cause the condition. This test is highly recommended for individuals presenting with symptoms suggestive of agammaglobulinemia type 2 or for those with a family history of the condition. Early diagnosis through genetic testing can significantly improve the management of the disease, reduce the occurrence of infections, and enhance the overall quality of life.
Conclusion
Agammaglobulinemia type 2 is a rare genetic disorder that poses significant challenges due to its impact on the immune system. Recognizing the symptoms early and opting for genetic testing can lead to a timely diagnosis, which is crucial for effective management. DNA Labs UAE provides a comprehensive genetic test for IGLL1 Gene Agammaglobulinemia type 2 autosomal recessive condition, aiding in the early detection and management of this condition. For more details on the test and to schedule an appointment, visit [DNA Labs UAE](https://dnalabsuae.com/tests/igll1-gene-agammaglobulinemia-type-2-autosomal-recessive-genetic-test/).
